KOREA PHARMA Co., Ltd.: debt-to-equity, ROE and more
KOSDAQ, Legal name KOREA PHARMA Co., Ltd.
Latest figures are the FY2025 separate summary statements.
Latest fiscal year ratios (computed here)
- Debt/equity
- 84.1%
- Equity ratio
- 54.3%
- ROE
- -3.8%
- Op. margin
- -1.0%
- Rev. growth
- 7.8%
- Interest coverage
- n/a
Condition flags
- Latest operating profit is not above zero, or not reported.
- Operating loss for 1 straight year.
- Total equity is above paid-in capital. Not capital-impaired.
Interest coverage and dividends (OpenDART)
Interest expense and dividends come from DART's OpenDART annual-report filings, not the FSC summary statements used above. The source differs from the other tables on this page.
Interest coverage = operating profit ÷ interest expenseNo interest expense value yet for this company. Most companies fold interest expense into a single finance-costs line on their income statement, so it cannot be pulled out separately. Interest coverage is not computed here.
Dividends, last 3 fiscal years
| Fiscal year | Cash dividend per share | Payout ratio |
|---|---|---|
| 2025 | ₩50 | n/a |
| 2024 | ₩50 | n/a |
| 2023 | ₩50 | n/a |
Cash dividends for 3 straight years (only the 3 years OpenDART returns).
Source values from the OpenDART (금융감독원 전자공시) annual report. Report fiscal year 2025.
Ratios by year (computed here)
Debt-to-equity = total liabilities ÷ total equity × 100Equity ratio = total equity ÷ total assets × 100ROE = net income ÷ year-end total equity × 100Operating margin = operating profit ÷ revenue × 100Revenue growth = (this year − last year) ÷ last year × 100
Computed from the source figures above with these formulas. Where the source's own debt-to-equity differs from ours, both are shown for that year.
| Fiscal year | Debt/equity | Equity ratio | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| FY2021 separate | 125.2% | 44.4% | 11.1% | 6.3% | n/a |
| FY2022 separate | 118.9% | 45.7% | -1.9% | 7.6% | 1.8% |
| FY2023 separate | 76.9% | 56.5% | 0.1% | 7.5% | 2.7% |
| FY2024 separate | 57.3% | 63.6% | 5.3% | 7.5% | -2.4% |
| FY2025 separate | 84.1% | 54.3% | -3.8% | -1.0% | 7.8% |
Source figures (FSC summary statements)
Amounts are the source values, shortened. A cell reported as zero may be blank in the source, so it is not used in any ratio.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | ₩79.6B | ₩81.0B | ₩83.2B | ₩81.3B | ₩87.6B |
| Operating profit | ₩5.0B | ₩6.2B | ₩6.3B | ₩6.1B | -₩887.3M |
| Pre-tax income | ₩5.2B | -₩1.8B | ₩2.0B | ₩3.9B | -₩4.5B |
| Net income | ₩6.4B | -₩1.1B | ₩83.8M | ₩3.8B | -₩2.6B |
| Total assets | ₩129.4B | ₩130.9B | ₩121.3B | ₩112.4B | ₩126.6B |
| Total liabilities | ₩71.9B | ₩71.1B | ₩52.7B | ₩40.9B | ₩57.9B |
| Total equity | ₩57.5B | ₩59.8B | ₩68.6B | ₩71.4B | ₩68.8B |
| Paid-in capital | ₩5.5B | ₩5.5B | ₩5.5B | ₩5.5B | ₩5.5B |
| Debt/equity (source value) | 125.2% | 118.9% | 76.9% | 57.3% | 84.1% |
Company outline (FSC)
- Market
- KOSDAQ
- Fiscal year end
- Dec
- Founded
- 1985-12-24
- Listed
- 20/08/10
- Employees
- 284
- Auditor
- 신한회계법인
- Audit opinion
- 적정의견
- Corporate reg. no.
- 1801110059112
- Outline updated
- 2026-09-24
Check the original filings
Read the annual report and audit report before you decide anything. The link opens a DART search for this company's name.
Search DART for 한국파마Computed from the Financial Services Commission's company outline and summary statements (data.go.kr). Data as of 2026-09-24.